Brett Chapman is a Technical Product Specialist for the Roche Diagnostics cobas I 601 Mass Spec product line in Australia and New Zealand, focusing on the integration of automated Mass Spectrometry in core diagnostics testing labs since October 2025. Prior to this, Brett served as a Life Science Accreditation Advisory Committee Member at the National Association of Testing Authorities and worked as a Technical Assessor for molecular testing and bioinformatics from March 2023 to October 2025. Brett's extensive experience in the field includes various roles at Agena Bioscience, with responsibilities ranging from cross-functional leadership and project management to customer support and assay validation. Earlier career roles include a Research Assistant at QIMR Berghofer and a Laboratory Technician at AGRF Ltd. Brett is currently pursuing an MBA at Queensland University of Technology and holds a Graduate Certificate in Biotechnology Industries and a degree in Applied Science, Biochemistry and Biotechnology.
This person is not in any teams
This person is not in any offices